Request for Covid-19 Impact Assessment of this Report
The United States Nicardipine Hydrochloride Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nicardipine Hydrochloride Injection market, reaching US$ million by the year 2028. As for the Europe Nicardipine Hydrochloride Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nicardipine Hydrochloride Injection players cover Baxter, Hikma, Mylan, and Sun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nicardipine Hydrochloride Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
20 mg / 200 mL
40 mg / 200 mL
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Recovery Center
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
Hikma
Mylan
Sun Pharma
Chiesi
Wockhardt
DMS Pharmaceutical
Sandoz
Navinta
Teva
Shanghai Furen Medicine
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nicardipine Hydrochloride Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nicardipine Hydrochloride Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nicardipine Hydrochloride Injection by Country/Region, 2017, 2022 & 2028
2.2 Nicardipine Hydrochloride Injection Segment by Type
2.2.1 20 mg / 200 mL
2.2.2 40 mg / 200 mL
2.3 Nicardipine Hydrochloride Injection Sales by Type
2.3.1 Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Nicardipine Hydrochloride Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nicardipine Hydrochloride Injection Sale Price by Type (2017-2022)
2.4 Nicardipine Hydrochloride Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Recovery Center
2.5 Nicardipine Hydrochloride Injection Sales by Application
2.5.1 Global Nicardipine Hydrochloride Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Nicardipine Hydrochloride Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nicardipine Hydrochloride Injection Sale Price by Application (2017-2022)
3 Global Nicardipine Hydrochloride Injection by Company
3.1 Global Nicardipine Hydrochloride Injection Breakdown Data by Company
3.1.1 Global Nicardipine Hydrochloride Injection Annual Sales by Company (2020-2022)
3.1.2 Global Nicardipine Hydrochloride Injection Sales Market Share by Company (2020-2022)
3.2 Global Nicardipine Hydrochloride Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Nicardipine Hydrochloride Injection Revenue by Company (2020-2022)
3.2.2 Global Nicardipine Hydrochloride Injection Revenue Market Share by Company (2020-2022)
3.3 Global Nicardipine Hydrochloride Injection Sale Price by Company
3.4 Key Manufacturers Nicardipine Hydrochloride Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nicardipine Hydrochloride Injection Product Location Distribution
3.4.2 Players Nicardipine Hydrochloride Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nicardipine Hydrochloride Injection by Geographic Region
4.1 World Historic Nicardipine Hydrochloride Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Nicardipine Hydrochloride Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nicardipine Hydrochloride Injection Annual Revenue by Geographic Region
4.2 World Historic Nicardipine Hydrochloride Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Nicardipine Hydrochloride Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nicardipine Hydrochloride Injection Annual Revenue by Country/Region
4.3 Americas Nicardipine Hydrochloride Injection Sales Growth
4.4 APAC Nicardipine Hydrochloride Injection Sales Growth
4.5 Europe Nicardipine Hydrochloride Injection Sales Growth
4.6 Middle East & Africa Nicardipine Hydrochloride Injection Sales Growth
5 Americas
5.1 Americas Nicardipine Hydrochloride Injection Sales by Country
5.1.1 Americas Nicardipine Hydrochloride Injection Sales by Country (2017-2022)
5.1.2 Americas Nicardipine Hydrochloride Injection Revenue by Country (2017-2022)
5.2 Americas Nicardipine Hydrochloride Injection Sales by Type
5.3 Americas Nicardipine Hydrochloride Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nicardipine Hydrochloride Injection Sales by Region
6.1.1 APAC Nicardipine Hydrochloride Injection Sales by Region (2017-2022)
6.1.2 APAC Nicardipine Hydrochloride Injection Revenue by Region (2017-2022)
6.2 APAC Nicardipine Hydrochloride Injection Sales by Type
6.3 APAC Nicardipine Hydrochloride Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nicardipine Hydrochloride Injection by Country
7.1.1 Europe Nicardipine Hydrochloride Injection Sales by Country (2017-2022)
7.1.2 Europe Nicardipine Hydrochloride Injection Revenue by Country (2017-2022)
7.2 Europe Nicardipine Hydrochloride Injection Sales by Type
7.3 Europe Nicardipine Hydrochloride Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nicardipine Hydrochloride Injection by Country
8.1.1 Middle East & Africa Nicardipine Hydrochloride Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nicardipine Hydrochloride Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Nicardipine Hydrochloride Injection Sales by Type
8.3 Middle East & Africa Nicardipine Hydrochloride Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nicardipine Hydrochloride Injection
10.3 Manufacturing Process Analysis of Nicardipine Hydrochloride Injection
10.4 Industry Chain Structure of Nicardipine Hydrochloride Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nicardipine Hydrochloride Injection Distributors
11.3 Nicardipine Hydrochloride Injection Customer
12 World Forecast Review for Nicardipine Hydrochloride Injection by Geographic Region
12.1 Global Nicardipine Hydrochloride Injection Market Size Forecast by Region
12.1.1 Global Nicardipine Hydrochloride Injection Forecast by Region (2023-2028)
12.1.2 Global Nicardipine Hydrochloride Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nicardipine Hydrochloride Injection Forecast by Type
12.7 Global Nicardipine Hydrochloride Injection Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Nicardipine Hydrochloride Injection Product Offered
13.1.3 Baxter Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Hikma
13.2.1 Hikma Company Information
13.2.2 Hikma Nicardipine Hydrochloride Injection Product Offered
13.2.3 Hikma Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Hikma Main Business Overview
13.2.5 Hikma Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Nicardipine Hydrochloride Injection Product Offered
13.3.3 Mylan Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Sun Pharma
13.4.1 Sun Pharma Company Information
13.4.2 Sun Pharma Nicardipine Hydrochloride Injection Product Offered
13.4.3 Sun Pharma Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sun Pharma Main Business Overview
13.4.5 Sun Pharma Latest Developments
13.5 Chiesi
13.5.1 Chiesi Company Information
13.5.2 Chiesi Nicardipine Hydrochloride Injection Product Offered
13.5.3 Chiesi Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Chiesi Main Business Overview
13.5.5 Chiesi Latest Developments
13.6 Wockhardt
13.6.1 Wockhardt Company Information
13.6.2 Wockhardt Nicardipine Hydrochloride Injection Product Offered
13.6.3 Wockhardt Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Wockhardt Main Business Overview
13.6.5 Wockhardt Latest Developments
13.7 DMS Pharmaceutical
13.7.1 DMS Pharmaceutical Company Information
13.7.2 DMS Pharmaceutical Nicardipine Hydrochloride Injection Product Offered
13.7.3 DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 DMS Pharmaceutical Main Business Overview
13.7.5 DMS Pharmaceutical Latest Developments
13.8 Sandoz
13.8.1 Sandoz Company Information
13.8.2 Sandoz Nicardipine Hydrochloride Injection Product Offered
13.8.3 Sandoz Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sandoz Main Business Overview
13.8.5 Sandoz Latest Developments
13.9 Navinta
13.9.1 Navinta Company Information
13.9.2 Navinta Nicardipine Hydrochloride Injection Product Offered
13.9.3 Navinta Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Navinta Main Business Overview
13.9.5 Navinta Latest Developments
13.10 Teva
13.10.1 Teva Company Information
13.10.2 Teva Nicardipine Hydrochloride Injection Product Offered
13.10.3 Teva Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Teva Main Business Overview
13.10.5 Teva Latest Developments
13.11 Shanghai Furen Medicine
13.11.1 Shanghai Furen Medicine Company Information
13.11.2 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product Offered
13.11.3 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Shanghai Furen Medicine Main Business Overview
13.11.5 Shanghai Furen Medicine Latest Developments
14 Research Findings and Conclusion
Table 1. Nicardipine Hydrochloride Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nicardipine Hydrochloride Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 20 mg / 200 mL
Table 4. Major Players of 40 mg / 200 mL
Table 5. Global Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 6. Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2022)
Table 7. Global Nicardipine Hydrochloride Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Nicardipine Hydrochloride Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 12. Global Nicardipine Hydrochloride Injection Revenue by Application (2017-2022)
Table 13. Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Nicardipine Hydrochloride Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Nicardipine Hydrochloride Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Nicardipine Hydrochloride Injection Sales Market Share by Company (2020-2022)
Table 17. Global Nicardipine Hydrochloride Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Nicardipine Hydrochloride Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Nicardipine Hydrochloride Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Nicardipine Hydrochloride Injection Producing Area Distribution and Sales Area
Table 21. Players Nicardipine Hydrochloride Injection Products Offered
Table 22. Nicardipine Hydrochloride Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nicardipine Hydrochloride Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Nicardipine Hydrochloride Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Nicardipine Hydrochloride Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Nicardipine Hydrochloride Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Nicardipine Hydrochloride Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Nicardipine Hydrochloride Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Nicardipine Hydrochloride Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Nicardipine Hydrochloride Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Nicardipine Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Nicardipine Hydrochloride Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Nicardipine Hydrochloride Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Nicardipine Hydrochloride Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Nicardipine Hydrochloride Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Nicardipine Hydrochloride Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Nicardipine Hydrochloride Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Nicardipine Hydrochloride Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 46. APAC Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Nicardipine Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Nicardipine Hydrochloride Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Nicardipine Hydrochloride Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Nicardipine Hydrochloride Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Nicardipine Hydrochloride Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Nicardipine Hydrochloride Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Nicardipine Hydrochloride Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Nicardipine Hydrochloride Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Nicardipine Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Nicardipine Hydrochloride Injection
Table 66. Key Market Challenges & Risks of Nicardipine Hydrochloride Injection
Table 67. Key Industry Trends of Nicardipine Hydrochloride Injection
Table 68. Nicardipine Hydrochloride Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Nicardipine Hydrochloride Injection Distributors List
Table 71. Nicardipine Hydrochloride Injection Customer List
Table 72. Global Nicardipine Hydrochloride Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Nicardipine Hydrochloride Injection Sales Market Forecast by Region
Table 74. Global Nicardipine Hydrochloride Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Nicardipine Hydrochloride Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Nicardipine Hydrochloride Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Nicardipine Hydrochloride Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Nicardipine Hydrochloride Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Nicardipine Hydrochloride Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Nicardipine Hydrochloride Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Nicardipine Hydrochloride Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Nicardipine Hydrochloride Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Nicardipine Hydrochloride Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Nicardipine Hydrochloride Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Nicardipine Hydrochloride Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Nicardipine Hydrochloride Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Nicardipine Hydrochloride Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Nicardipine Hydrochloride Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Nicardipine Hydrochloride Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Nicardipine Hydrochloride Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Nicardipine Hydrochloride Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Baxter Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Baxter Nicardipine Hydrochloride Injection Product Offered
Table 94. Baxter Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Baxter Main Business
Table 96. Baxter Latest Developments
Table 97. Hikma Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Hikma Nicardipine Hydrochloride Injection Product Offered
Table 99. Hikma Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Hikma Main Business
Table 101. Hikma Latest Developments
Table 102. Mylan Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Mylan Nicardipine Hydrochloride Injection Product Offered
Table 104. Mylan Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Mylan Main Business
Table 106. Mylan Latest Developments
Table 107. Sun Pharma Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharma Nicardipine Hydrochloride Injection Product Offered
Table 109. Sun Pharma Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Sun Pharma Main Business
Table 111. Sun Pharma Latest Developments
Table 112. Chiesi Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Chiesi Nicardipine Hydrochloride Injection Product Offered
Table 114. Chiesi Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Chiesi Main Business
Table 116. Chiesi Latest Developments
Table 117. Wockhardt Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Wockhardt Nicardipine Hydrochloride Injection Product Offered
Table 119. Wockhardt Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Wockhardt Main Business
Table 121. Wockhardt Latest Developments
Table 122. DMS Pharmaceutical Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. DMS Pharmaceutical Nicardipine Hydrochloride Injection Product Offered
Table 124. DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. DMS Pharmaceutical Main Business
Table 126. DMS Pharmaceutical Latest Developments
Table 127. Sandoz Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Sandoz Nicardipine Hydrochloride Injection Product Offered
Table 129. Sandoz Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Sandoz Main Business
Table 131. Sandoz Latest Developments
Table 132. Navinta Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Navinta Nicardipine Hydrochloride Injection Product Offered
Table 134. Navinta Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Navinta Main Business
Table 136. Navinta Latest Developments
Table 137. Teva Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Teva Nicardipine Hydrochloride Injection Product Offered
Table 139. Teva Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Teva Main Business
Table 141. Teva Latest Developments
Table 142. Shanghai Furen Medicine Basic Information, Nicardipine Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product Offered
Table 144. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Shanghai Furen Medicine Main Business
Table 146. Shanghai Furen Medicine Latest Developments
List of Figures
Figure 1. Picture of Nicardipine Hydrochloride Injection
Figure 2. Nicardipine Hydrochloride Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nicardipine Hydrochloride Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Nicardipine Hydrochloride Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nicardipine Hydrochloride Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 20 mg / 200 mL
Figure 10. Product Picture of 40 mg / 200 mL
Figure 11. Global Nicardipine Hydrochloride Injection Sales Market Share by Type in 2021
Figure 12. Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2017-2022)
Figure 13. Nicardipine Hydrochloride Injection Consumed in Hospital
Figure 14. Global Nicardipine Hydrochloride Injection Market: Hospital (2017-2022) & (K Units)
Figure 15. Nicardipine Hydrochloride Injection Consumed in Clinic
Figure 16. Global Nicardipine Hydrochloride Injection Market: Clinic (2017-2022) & (K Units)
Figure 17. Nicardipine Hydrochloride Injection Consumed in Recovery Center
Figure 18. Global Nicardipine Hydrochloride Injection Market: Recovery Center (2017-2022) & (K Units)
Figure 19. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2017-2022)
Figure 20. Global Nicardipine Hydrochloride Injection Revenue Market Share by Application in 2021
Figure 21. Nicardipine Hydrochloride Injection Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Nicardipine Hydrochloride Injection Revenue Market Share by Company in 2021
Figure 23. Global Nicardipine Hydrochloride Injection Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Nicardipine Hydrochloride Injection Revenue Market Share by Geographic Region in 2021
Figure 25. Global Nicardipine Hydrochloride Injection Sales Market Share by Region (2017-2022)
Figure 26. Global Nicardipine Hydrochloride Injection Revenue Market Share by Country/Region in 2021
Figure 27. Americas Nicardipine Hydrochloride Injection Sales 2017-2022 (K Units)
Figure 28. Americas Nicardipine Hydrochloride Injection Revenue 2017-2022 ($ Millions)
Figure 29. APAC Nicardipine Hydrochloride Injection Sales 2017-2022 (K Units)
Figure 30. APAC Nicardipine Hydrochloride Injection Revenue 2017-2022 ($ Millions)
Figure 31. Europe Nicardipine Hydrochloride Injection Sales 2017-2022 (K Units)
Figure 32. Europe Nicardipine Hydrochloride Injection Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Nicardipine Hydrochloride Injection Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Nicardipine Hydrochloride Injection Revenue 2017-2022 ($ Millions)
Figure 35. Americas Nicardipine Hydrochloride Injection Sales Market Share by Country in 2021
Figure 36. Americas Nicardipine Hydrochloride Injection Revenue Market Share by Country in 2021
Figure 37. United States Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Nicardipine Hydrochloride Injection Sales Market Share by Region in 2021
Figure 42. APAC Nicardipine Hydrochloride Injection Revenue Market Share by Regions in 2021
Figure 43. China Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Nicardipine Hydrochloride Injection Sales Market Share by Country in 2021
Figure 50. Europe Nicardipine Hydrochloride Injection Revenue Market Share by Country in 2021
Figure 51. Germany Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Nicardipine Hydrochloride Injection Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Nicardipine Hydrochloride Injection Revenue Market Share by Country in 2021
Figure 58. Egypt Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Nicardipine Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Nicardipine Hydrochloride Injection in 2021
Figure 64. Manufacturing Process Analysis of Nicardipine Hydrochloride Injection
Figure 65. Industry Chain Structure of Nicardipine Hydrochloride Injection
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...